Results 241 to 250 of about 175,041 (315)

Deep Understanding of Vaginal Microbiota in HPV‐Related Diseases From a Multi‐Omics Perspective

VIEW Medicine, Volume 1, Issue 1, August 2026.
Current understanding of the vaginal microbiota and roles of critical vaginal bacteria, including Lactobacillus and anaerobic pathogens, in human papillomavirus (HPV) infection and HPV‐related diseases from a multi‐omics perspective. ABSTRACT There is a large number of microorganisms in the human body, which are inseparable from human health.
Jianxujie Zheng, Qing Cong, Ling Lin, Liang Qiao   +3 more
wiley   +1 more source

The association of pathological findings in HPV-31 positive women with high-grade squamous intraepithelial lesions. [PDF]

J Turk Ger Gynecol Assoc
Buran A, Altaş H, Özkaya Uçar Y, Tokalıoğlu AA, Tiryaki Güner G, Aytekin O, Kılıç F, Turan T.   +7 more
europepmc   +1 more source

Increased cervical cancer incidence in the target age of screening—Variation by mode of detection

International Journal of Cancer, Volume 159, Issue 2, Page 359-367, 15 July 2026.
What's new? Cervical cancer rates have risen in several high‐income countries despite advances in screening. Here, using data on cervical cancer diagnoses between 1996 and 2022 in Finland, the authors examined incidence trends according to detection mode—screening, between screenings, or outside screening programs—with attention to the role of human ...
Jenna Snellman, Maiju Pankakoski, Sirpa Heinävaara, Veli‐Matti Partanen, Maija Vahteristo   +4 more
wiley   +1 more source

Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey. [PDF]

PLoS One
Assefa KT, Worku AG, Muche AA, Geremew BM, Woldetsadik MA, Alemu K.   +5 more
europepmc   +1 more source

Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage

International Journal of Cancer, Volume 159, Issue 2, Page 389-400, 15 July 2026.
What's new? Effective cervical cancer prevention centers around screening and testing for human papillomavirus (HPV) infection. With birth cohorts of HPV‐vaccinated women now reaching screening‐eligible ages, however, the best means to maintaining cost‐effective cervical cancer screening is unclear.
Tiago M. de Carvalho, Johannes Berkhof, Johannes A. Bogaards   +2 more
wiley   +1 more source

Risk Factors and Delivery Outcomes Among Women Diagnosed With Human Papillomavirus Prior to Pregnancy Comparing High-Risk and Low-Risk Strains: A Retrospective Chart Review. [PDF]

Cureus
Manzo M, Hock EA, Aguilar NN, Griepp AT, Surma J, Cheng CI, Kinaschuk V.   +6 more
europepmc   +1 more source

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie, Kara A. Gray‐Burrows, Peter F. Day, Bob Phillips, Carl A. Thompson   +4 more
wiley   +1 more source

Association of Oral Papivir/Pavirona^® Supplementation with HPV DNA Clearance. [PDF]

Viruses
Gungor Serin B, Temiz BE, Tuncer H, Atakul MO, Gunes AC, Onat T, Akgor U, Basaran D, Tuncer ZS, Gultekin M.   +9 more
europepmc   +1 more source

Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 160-167, July 2026.
Cadmium exposure causes serious health consequences; however, there is no clinically approved antidote for cadmium poisoning. This Phase 1a/1b trial aimed to investigate safety, tolerability, and pharmacokinetics of Sodium (S)‐2‐(dithiocarboxylato((2S,3R,4R,5R)‐2,3,4,5,6‐pentahydroxyhexyl) amino)‐4‐(methylthio) butanoate (GMDTC), a novel chelating ...
Xuefeng Ren, Wei Hu, Xiaobin Deng, Rong Ma, Fang Pei, Xushen Chen, Xuemei Wang, Jixin Tang, Yan Lai, Shangming Pan, Zhiyong Zhong, Sheng Fu, Huamin Yuan, Juan Yuan, Chuntao Huang, Yuan Zeng, Xiaodong Ying, Guanghui Dong, Jinxin Zhang, Jinyuan Zhao, Kangguang Lin, Xiaojiang Tang   +21 more
wiley   +1 more source

Survey to Document the Adverse Reactions After Human Papillomavirus Vaccination Among Japanese Female Youth at a University. [PDF]

J Obstet Gynaecol Res
Higuchi C, Ogawa C, Iwasaki Y, Hagiya H, Masuyama H.   +4 more
europepmc   +1 more source